Skip to main content
REVB logo
REVB
(NASDAQ)
Revelation Biosciences, Inc.
$1.04-- (--)
Loading... - Market loading

Revelation Biosciences (REVB) Stock Price & Financial Analysis

Revelation Biosciences Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.99 - $1.05
52-Week High$9.97
52-Week Low$0.88
Open$1.03
Volume21.95K
Average Volume (3M)80.52K
Market Cap645.63K
Shares Outstanding620.80K
Price to Book (P/B)0.07
EV/EBITDA1.03
50-Day MA$1.18
200-Day MA$2.29
52-Week Change-90.00%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Revelation Biosciences

What is the current stock price for REVB?

As of the latest trading session, REVB stock trades at $1.03. The 52-week range is $0.88–$9.97, with a day range of $0.99–$1.04.

What is the P/E ratio for REVB?

The P/E ratio (Price-to-Earnings) for REVB is shown in the Key Statistics section. This valuation metric helps compare Revelation Biosciences, Inc. to industry peers.

Does REVB pay dividends?

Revelation Biosciences does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for REVB?

Analyst ratings and recommendations for REVB are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of REVB?

Revelation Biosciences's market capitalization is $639,424, classifying it as a micro-cap company. Revelation Biosciences operates in the Healthcare sector within the Biotechnology industry.